glp-1 cena Battery Booster – regulator apetita, glukoze i sitosti The Rise of the GLP-1s:

Obesity and weight management is the leading segment, accounting for USD 1.1 billion in terms of revenue with 18.7% CAGR, based on effective weight loss results as key differentiators in the clinic

1-4 Together with lifestyle changes such as eating a healthier balanced diet and being more active, GLP-1 RAs help support weight loss

The platforms real-time messaging with providers, transparent documentation, and monthly check-ins ensure patients feel heard and guided throughout their journey

Current practice While authoritative health and medical entities recommend comprehensive lifestyle modification as part of the treatment plan for obesity, the use of such therapies prior to or to support GLP-1 use is not widespread in practice

In Canada, agents such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are rapidly becoming part of the everyday medication list